Logix Initiative for Greater Acceptance of Logistics Properties
Oct 6, 2021 at 2:13 PM
HHLA Presents Future Projects at ITS World Congress in Hamburg
Oct 6, 2021 at 2:31 PM
The specialized logistics service provider LOXXESS expanded its long-standing participation as the largest shareholder of LOXXESS Pharma GmbH in August 2021 and acquired 100% of the shares in the logistics specialist for pharmaceutical distribution. The processes, services, and jobs of both companies will not be affected by this change. However, an expansion of capabilities and synergies for customers is expected.
(Tegernsee/Neutraubling) The logistics and fulfillment service provider LOXXESS AG, Tegernsee, has acquired all shares from the previously involved partners, Aenova Holding GmbH, Alloga S.à.r.l., and Haupt Pharma Wolfratshausen GmbH. LOXXESS Pharma is headquartered in Neutraubling near Regensburg and offers modular logistics and distribution solutions for customers in the pharmaceutical industry, the medtech sector, and the premium cosmetics market, currently employing 180 staff at three locations in Bavaria. Approximately 1.2 billion pharmaceutical packages are handled annually. LOXXESS AG also has a strong network and long-standing expertise in the field of pharmaceutical logistics, for example, for the customer HARTMANN at the Henstedt-Ulzburg location.
“Through the acquisition, we can combine the strengths and know-how of both companies, thereby creating synergies. Given that the complexity of pharmaceutical products will increase and the market continues to grow, both companies are now excellently positioned for planned site expansions,” explains LOXXESS board member Christina Thurner.
Organically grown
Since its founding in 2000, LOXXESS Pharma, like LOXXESS AG, has grown organically and provides high-level services, as evidenced by its commitment to compliance with GDP (Good Distribution Practice) and GSP (Good Storage Practice) guidelines. LOXXESS Pharma is already active across Europe: Through integration into the Alloga Europe network, the specialized service provider can modularly access services in 15 European countries. In the future, services and the network can be extended to further LOXXESS locations in Germany, the Czech Republic, and Poland.
Otto Prange, the former chairman of the advisory board representing Aenova, comments on the transaction: “Bringing the shares together in one unit under the proven expertise of the LOXXESS shareholders offers important advantages for LOXXESS Pharma. This will enable the company to further expand its multinational distribution solutions in the future. This opens up new market opportunities for our joint customers – thus, the unification of the shares at LOXXESS is a logical and correct step.”
Continue to operate independently
On behalf of his colleagues in management, Dr. Beate Grudzus-Zager and Dr. Tilman Spaethe, Johann Strobl, Managing Director Operations | Digital | Sales at LOXXESS Pharma, says: “The operational collaboration with LOXXESS can be further expanded as a result of the share acquisition. At the same time, we will continue to operate independently in our segment as a specialized service provider for the pharmaceutical market and meet future customer requirements with innovative concepts and services.”
LOXXESS AG employs approximately 2,600 staff at 26 locations in Germany, Poland, and the Czech Republic. Overall, the logistics service provider has 600,000 square meters of covered hall space and achieved a revenue of 175 million euros in 2020.
Photo: © Loxxess Pharma / Image caption: Dr. Tilman Spaethe, Managing Director Finance, HR, Service Center; Dr. Beate Grudzus-Zager, Managing Director Manufacturing, Quality, Regulatory Compliance, and Johann Strobl, Managing Director Operations (all LOXXESS Pharma)
